The mysterious ρ -between or within studies [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2018-02-11 17:31 (1437 d 07:20 ago) – Posting: # 18396
Views: 13,838

Dear Detlew

» That's not the whole truth about the state of affairs :no:.
» The question is: Correlation of treatment differences between studies or within studies.
» For the latter I recall you two references:
» Phillips KF.
» Power for Testing Multiple Instances of the Two One-Sided Tests Procedure
» Int J Biostat. 2009;5(1):Article 15. doi:10.2202/1557-4679.1169
» Quote from Kem Phillips:
» "The correlation will usually be difficult to estimate, unless a similar experiment has been conducted...".
» That smells for me like within a study.

Yep, then I expect a high correlation (based on my limited knowledge of PK). For my data sets I get with
pearson <- cor.test(log(study$AUC), log(study$Cmax))
rho[set, "estimate"] <- pearson$estimate
rho[set, "lower"]    <- as.numeric(pearson$[[1]]
rho[set, "upper"]    <- as.numeric(pearson$[[2]]
summary(rho, digits=5)

    estimate           lower               upper     
 Min.   :0.20123   Min.   :-0.094923   Min.   :0.40858
 1st Qu.:0.70335   1st Qu.: 0.516584   1st Qu.:0.82721

 Median :0.81713   Median : 0.677607   Median :0.89959
 Mean   :0.77413   Mean   : 0.633948   Mean   :0.86544
 3rd Qu.:0.90122   3rd Qu.: 0.827646   3rd Qu.:0.94461
 Max.   :0.98928   Max.   : 0.977336   Max.   :0.99494

IIRC, Chow & Liu state somewhere that the mean of within-subject ratios is a biased estimate…

Another question: What is a “similar experiment”? Given the dispersion in the summary above I would rather say that trying to get an estimate across different drugs (or even for the same drug but IR/IR and MR/MR) is futile. Will try again with the analyte as a factor.

Dif-tor heh smusma 🖖
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

 Admin contact
21,831 posts in 4,567 threads, 1,553 registered users;
online 12 (0 registered, 12 guests [including 5 identified bots]).
Forum time: Wednesday 00:52 CET (Europe/Vienna)

Research under a paradigm must be a particularly effective way
of inducing paradigm change.    Thomas S. Kuhn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz